Literature DB >> 29141563

Ganoderma lucidum Polysaccharides as An Anti-cancer Agent.

Didem Sohretoglu1,2, Shile Huang2,3.   

Abstract

The mushroom Ganoderma lucidum (G. lucidum) has been used for centuries in Asian countries to treat various diseases and to promote health and longevity. Clinical studies have shown beneficial effects of G. lucidum as an alternative adjuvant therapy in cancer patients without obvious toxicity. G. lucidum polysaccharides (GLP) is the main bioactive component in the water soluble extracts of this mushroom. Evidence from in vitro and in vivo studies has demonstrated that GLP possesses potential anticancer activity through immunomodulatory, anti-proliferative, pro-apoptotic, anti-metastatic and anti-angiogenic effects. Here, we briefly summarize these anticancer effects of GLP and the underlying mechanisms. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Ganoderma lucidum polysaccharides; Reishi; anti-angiogenic; anti-cancer; anti-metastatic; anti-proliferative; immunomodulatory; pro-apoptotic.

Mesh:

Substances:

Year:  2018        PMID: 29141563      PMCID: PMC6624854          DOI: 10.2174/1871520617666171113121246

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  26 in total

Review 1.  How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology?

Authors:  Yulia Kirdeeva; Olga Fedorova; Alexandra Daks; Nikolai Barlev; Oleg Shuvalov
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-14

2.  Regulation of Nrf2 and Nrf2-related proteins by ganoderma lucidum ın hepatocellular carcinoma.

Authors:  Ramin Aslaminabad; Negin Rahimianshahreza; Seyed Amirhossein Hosseini; Güliz Armagan; Ahmad Kashif Khan; Gülüzar Özbolat; Omar Saad Ahmed; Amir Mardi Azar; Ali Adili; Taner Dağcı; Sibel Konyalıoğlu; Ali Mert Özgönül
Journal:  Mol Biol Rep       Date:  2022-08-29       Impact factor: 2.742

Review 3.  Research Progress on the Anticancer Activities and Mechanisms of Polysaccharides From Ganoderma.

Authors:  Man Wang; Fei Yu
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

4.  Investigation of HER-3 gene expression under the influence of carbohydrate biopolymers extract of shiitake and reishi in MCF-7 cell line.

Authors:  Mohaddeseh Larypoor
Journal:  Mol Biol Rep       Date:  2022-05-10       Impact factor: 2.742

Review 5.  Nutritional Interventions for Treating Cancer-Related Fatigue: A Qualitative Review.

Authors:  Julia E Inglis; Po-Ju Lin; Sarah L Kerns; Ian R Kleckner; Amber S Kleckner; Daniel A Castillo; Karen M Mustian; Luke J Peppone
Journal:  Nutr Cancer       Date:  2019-01-26       Impact factor: 2.900

6.  Chestnut polysaccharides benefit spermatogenesis through improvement in the expression of important genes.

Authors:  Shuai Yu; Yong Zhao; Fa-Li Zhang; Ya-Qi Li; Wei Shen; Zhong-Yi Sun
Journal:  Aging (Albany NY)       Date:  2020-06-21       Impact factor: 5.682

7.  ReishiMax inhibits mTORC1/2 by activating AMPK and inhibiting IGFR/PI3K/Rheb in tumor cells.

Authors:  Didem Sohretoglu; Chao Zhang; Jun Luo; Shile Huang
Journal:  Signal Transduct Target Ther       Date:  2019-06-28

8.  A New Triterpenoid Glucoside from a Novel Acidic Glycosylation of Ganoderic Acid A via Recombinant Glycosyltransferase of Bacillus subtilis.

Authors:  Te-Sheng Chang; Chien-Min Chiang; Yu-Han Kao; Jiumn-Yih Wu; Yu-Wei Wu; Tzi-Yuan Wang
Journal:  Molecules       Date:  2019-09-24       Impact factor: 4.411

9.  Ganoderma lucidum Exerts an Anticancer Effect on Human Osteosarcoma Cells via Suppressing the Wnt/β-Catenin Signaling Pathway.

Authors:  Qi-Hao Zhang; Qin-Xiao Hu; Da Xie; Bo Chang; Hou-Guang Miao; Yun-Guo Wang; De-Zhong Liu; Xue-Dong Li
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

10.  Ganoderma Lucidum Polysaccharides Enhance the Abscopal Effect of Photothermal Therapy in Hepatoma-Bearing Mice Through Immunomodulatory, Anti-Proliferative, Pro-Apoptotic and Anti-Angiogenic.

Authors:  Qing-Hai Xia; Cui-Tao Lu; Meng-Qi Tong; Meng Yue; Rui Chen; De-Li Zhuge; Qing Yao; He-Lin Xu; Ying-Zheng Zhao
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.